Atlas Trials

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia

Clinical trial NCT00378131 · COMPLETED

Trial details

NCT number
NCT00378131
Sponsor
Helsinn Therapeutics (U.S.), Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer Cachexia
Start date
2006-09-01
Primary completion
2007-04-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.